Epiminder Ltd (AU:EPI) — Market Cap & Net Worth
Market Cap & Net Worth: Epiminder Ltd (EPI)
Epiminder Ltd (AU:EPI) has a market capitalization of $42.93K (AU$60.67K) as of September 22, 2026. Listed on the AU stock exchange, this Australia-based company holds position #31667 globally and #1816 in its home market, demonstrating a -6.67% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Epiminder Ltd's stock price AU$0.28 by its total outstanding shares 216672 (216.67K). Also see EPI current and non-current assets for a full breakdown of the balance sheet.
Epiminder Ltd Market Cap History: 2025 to 2026
Epiminder Ltd's market capitalization history from 2025 to 2026. Data shows growth from $156.38K to $42.93K (0.00% CAGR). Also see Epiminder Ltd cash conversion from operations for how efficiently the company converts equity into cash flow.
Epiminder Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Epiminder Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check latest Epiminder Ltd stock price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.35x
Epiminder Ltd's market cap is 0.35 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $156.38K | $445.18K | -$31.78 Million | 0.35x | N/A |
Competitor Companies of EPI by Market Capitalization
Companies near Epiminder Ltd in the global market cap rankings as of September 22, 2026. Review EPI goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Epiminder Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #124 globally with a market cap of $179.07 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #238 globally with a market cap of $105.17 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #124 | Abbott Laboratories | NYSE:ABT | $179.07 Billion | $102.98 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $91.75 |
| #238 | Stryker Corporation | NYSE:SYK | $105.17 Billion | $274.19 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Epiminder Ltd Historical Marketcap From 2025 to 2026
Between 2025 and today, Epiminder Ltd's market cap moved from $156.38K to $ 42.93K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$42.93K | -72.55% |
| 2025 | AU$156.38K | -- |
End of Day Market Cap According to Different Sources
On Sep 22nd, 2026 the market cap of Epiminder Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $42.93K USD |
| MoneyControl | $42.93K USD |
| MarketWatch | $42.93K USD |
| marketcap.company | $42.93K USD |
| Reuters | $42.93K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Epiminder Ltd
Epiminder Limited develops and manufactures a monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions. It offers Minder system, an implantable sub scalp electroencephalography (EEG) monitoring system which is designed for continuous monitoring of brain activity. The company's Minder system comprises Minder implant, a sub scalp electrode with mul… Read more